Publications

Citation

BibTex format

@article{Baldeh:2024:10.1080/14737159.2023.2277368,
author = {Baldeh, M and Bawa, F and Bawah, F and Chamai, M and Dzabeng, F and Jebreel, W and Kabuya, J-B and Molemodile, Dele Olowu S and Rakotomalala, Robinson D and Cunnington, A},
doi = {10.1080/14737159.2023.2277368},
journal = {Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare},
pages = {153--159},
title = {Lessons from the pandemic: new best practices in selecting molecular diagnostics for point-of-care testing of infectious diseases in sub-Saharan Africa},
url = {http://dx.doi.org/10.1080/14737159.2023.2277368},
volume = {24},
year = {2024}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Introduction:Point-of-care molecular diagnostics offer solutions to the limited diagnostic availability and accessibility in resource-limited settings. During the COVID-19 pandemic, molecular diagnostics became essential tools for accurate detection and monitoring of SARS-CoV-2. The unprecedented demand for molecular diagnostics presented challenges and catalyzed innovations which may provide lessons for the future selection of point-of-care molecular diagnostics.Areas Covered:We searched PubMed from January 2020 to August 2023 to identify lessons learned from the COVID-19 pandemic which may impact the selection of point-of-care molecular diagnostics for future use in sub-Saharan Africa. We evaluated this in the context of REASSURED criteria (Real-time connectivity; Ease of specimen collection; Affordable; Sensitive; Specific; User-friendly; Rapid and robust; Equipment free; and Deliverable to users at the point of need) for point-of-care diagnostics for resource-limited settings.Expert Opinion:The diagnostic challenges and successes during the COVID-19 pandemic affirmed the importance of the REASSURED criteria but demonstrated that these are not sufficient to ensure new diagnostics will be appropriate for public health emergencies. Capacity for rapid scale-up of diagnostic testing and transferability of assays, data, and technology are also important, resulting in updated REST-ASSURED criteria. Few diagnostics will meet all criteria, and trade-offs between criteria will need to be context-specific.
AU  - Baldeh,M
AU  - Bawa,F
AU  - Bawah,F
AU  - Chamai,M
AU  - Dzabeng,F
AU  - Jebreel,W
AU  - Kabuya,J-B
AU  - Molemodile,Dele Olowu S
AU  - Rakotomalala,Robinson D
AU  - Cunnington,A
DO  - 10.1080/14737159.2023.2277368
EP  - 159
PY  - 2024///
SN  - 1473-7159
SP  - 153
TI  - Lessons from the pandemic: new best practices in selecting molecular diagnostics for point-of-care testing of infectious diseases in sub-Saharan Africa
T2  - Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare
UR  - http://dx.doi.org/10.1080/14737159.2023.2277368
UR  - https://www.tandfonline.com/doi/full/10.1080/14737159.2023.2277368
UR  - http://hdl.handle.net/10044/1/107571
VL  - 24
ER  -

Download

Citation

BibTex format

RIS format (EndNote, RefMan)

Subscribe